Schedule 13G ownership disclosure

NEWAMSTERDAM PHARMA COMPANY

Common Stock · CUSIP: N62509109

Event date: 2025-03-31

Filing-level shares
6,798,598.00
Percent of class
6.2%
  • Capital World Investors

    Shares: 6,798,598.00 · Class: 6.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001422848-25-000095
Form type
SCHEDULE 13G
Filer
Capital World Investors
CIK
CIK 1422849
Filed
May 13, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub